These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 1607241)
1. Inhibition of human subconjunctival fibroblast proliferation by immunotoxin. Wilkerson M; Fulcher S; Shields MB; Foulks GN; Hatchell DL; Houston LL Invest Ophthalmol Vis Sci; 1992 Jun; 33(7):2293-8. PubMed ID: 1607241 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of hematopoietic progenitor colony growth by a monoclonal antibody against the transferrin receptor: comparison of unconjugated antibody with an immunotoxin containing recombinant ricin A chain. Shannon KM; Ring DB; Houston LL; Schaffner V; Naylor J; Torkildson JC; Reid SA; Larrick J Int J Cell Cloning; 1990 Sep; 8(5):368-76. PubMed ID: 2230286 [TBL] [Abstract][Full Text] [Related]
3. Use of immunotoxin to inhibit proliferating human corneal endothelium. Fulcher S; Lui GM; Houston LL; Ramakrishnan S; Burris T; Polansky J; Alvarado J Invest Ophthalmol Vis Sci; 1988 May; 29(5):755-9. PubMed ID: 3259213 [TBL] [Abstract][Full Text] [Related]
4. Selective inhibition of growing pigment epithelial cells by a receptor-directed immunotoxin. Davis AA; Whidby DE; Privette T; Houston LL; Hunt RC Invest Ophthalmol Vis Sci; 1990 Dec; 31(12):2514-9. PubMed ID: 2265991 [TBL] [Abstract][Full Text] [Related]
5. The antiproliferative effect of a transferrin-toxin on human retinal pigment epithelial cells and rabbit fibroblasts. Handa JT; Houston LL; Jaffe GJ Invest Ophthalmol Vis Sci; 1993 Nov; 34(12):3419-28. PubMed ID: 8225877 [TBL] [Abstract][Full Text] [Related]
6. Cytotoxicity against human tumor cells mediated by the conjugate of anti-epidermal growth factor receptor monoclonal antibody to recombinant ricin A chain. Masui H; Kamrath H; Apell G; Houston LL; Mendelsohn J Cancer Res; 1989 Jul; 49(13):3482-8. PubMed ID: 2786451 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of human corneal epithelium with immunotoxin 454A12-rRA. Fulcher SF; Foulks GN; Wilkerson M; Cobo LM; Jaffe GJ; Hatchell DL Cornea; 1992 Sep; 11(5):413-7. PubMed ID: 1424670 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and toxicology of immunotoxins administered into the subarachnoid space in nonhuman primates and rodents. Muraszko K; Sung C; Walbridge S; Greenfield L; Dedrick RL; Oldfield EH; Youle RJ Cancer Res; 1993 Aug; 53(16):3752-7. PubMed ID: 8339287 [TBL] [Abstract][Full Text] [Related]
9. In vitro cytotoxicity of recombinant ricin A chain-antitransferrin receptor immunotoxin against human adenocarcinomas of the colon and pancreas. Griffin TW; Pagnini PG; McGrath JJ; McCann JC; Houston LL J Biol Response Mod; 1988 Dec; 7(6):559-67. PubMed ID: 3265147 [TBL] [Abstract][Full Text] [Related]
10. Cytotoxic activity of an anti-transferrin receptor immunotoxin on normal and leukemic human hematopoietic progenitors. Cazzola M; Bergamaschi G; Dezza L; D'Uva R; Ponchio L; Rosti V; Ascari E Cancer Res; 1991 Jan; 51(2):536-41. PubMed ID: 1985771 [TBL] [Abstract][Full Text] [Related]
11. Comparison of growth inhibition of a human ovarian adenocarcinoma cell line by free monoclonal antibodies and their corresponding antibody-recombinant ricin A chain immunotoxins. Ettenson D; Sheldon K; Marks A; Houston LL; Baumal R Anticancer Res; 1988; 8(4):833-8. PubMed ID: 3263079 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of transferrin receptor-targeted immunotoxins in brain tumor cell lines and pediatric brain tumors. Martell LA; Agrawal A; Ross DA; Muraszko KM Cancer Res; 1993 Mar; 53(6):1348-53. PubMed ID: 8443815 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of human tumor growth by intraperitoneal immunotoxins in nude mice. Marks A; Ettenson D; Bjorn MJ; Lei M; Baumal R Cancer Res; 1990 Jan; 50(2):288-92. PubMed ID: 2295069 [TBL] [Abstract][Full Text] [Related]
15. Antitumor activity of an immunotoxin in a nude mouse model of human ovarian cancer. FitzGerald DJ; Bjorn MJ; Ferris RJ; Winkelhake JL; Frankel AE; Hamilton TC; Ozols RF; Willingham MC; Pastan I Cancer Res; 1987 Mar; 47(5):1407-10. PubMed ID: 3493065 [TBL] [Abstract][Full Text] [Related]
16. Restoration of interferon alpha potentiation of a recombinant ricin A chain immunotoxin following cytoreduction of xenografts of advanced ovarian tumors. Pearson JW; Fogler WE; Volker K; Riggs CW; Gruys E; Groves ES; Wiltrout RH; Longo DL J Natl Cancer Inst; 1993 Jun; 85(11):907-12. PubMed ID: 8492319 [TBL] [Abstract][Full Text] [Related]
17. Potent cytotoxicity of an antihuman transferrin receptor-ricin A-chain immunotoxin on human glioma cells in vitro. Recht LD; Griffin TW; Raso V; Salimi AR Cancer Res; 1990 Oct; 50(20):6696-700. PubMed ID: 2208135 [TBL] [Abstract][Full Text] [Related]
18. Recombinant ricin A chain conjugated to monoclonal antibodies: improved tumor cell inhibition in the presence of lysosomotropic compounds. Ramakrishnan S; Bjorn MJ; Houston LL Cancer Res; 1989 Feb; 49(3):613-7. PubMed ID: 2783383 [TBL] [Abstract][Full Text] [Related]
20. Monensin in lipid emulsion for the potentiation of ricin A chain immunotoxins. Griffin T; Raso V Cancer Res; 1991 Aug; 51(16):4316-22. PubMed ID: 1868454 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]